Trials / Completed
CompletedNCT01502462
Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 131 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Prospective registry for patients with severe isolated tricuspid regurgitation (TR) without significant left-sided valvular or myocardial diseases. Aim: To evaluate clinical course and prognostic factors of patients with severe isolated TR.
Detailed description
Inclusion criteria Severe isolated TR for more than 6 months Exclusion criteria 1. Severe mitral and aortic valvular heart disease 2. Age equals to or more than 75 years 3. Malignancy or serious comorbidity with life expectancy \< 5years 4. Acute or subacute infective endocarditis requiring antibiotics therapy 5. Untreated hyperthyroidism 6. Constrictive pericarditis 7. Unclosed significant atrial septal defect 8. Previous tricuspid valve surgery 9. Significant coronary artery disease 10. Cardiomyopathy 11. Pregnancy 12. Severe resting pulmonary hypertension(TR Vmax \>4.0 m/s)
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2020-12-30
- Completion
- 2020-12-30
- First posted
- 2011-12-30
- Last updated
- 2021-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01502462. Inclusion in this directory is not an endorsement.